Goldenwell Biotech, Inc.
GWLLOTCConsumer Defensive● Active
$0.52
+$0.00(+0.00%)
Market Cap$51480000
P/E Ratio—
52W High$10
52W Low$0.2
Goldenwell Biotech, Inc. (GWLL) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · GWLL · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00M | $0.00M | $0.05M | $0.02M | $0.00M |
| Cost of Revenue | $0.00M | $0.00M | $0.02M | $0.01M | $0.00M |
| Gross Profit | $0.00M | $0.00M | $0.03M | $0.01M | $0.00M |
| Gross Margin %(computed) | 46.04% | 47.35% | 52.69% | 52.53% | — |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $0.12M | $0.12M | $1.01M | $0.13M | $0.01M |
| Total Operating Expenses | $0.12M | $0.12M | $1.01M | $0.13M | $0.01M |
| Operating Income | ($0.12M) | ($0.12M) | ($0.99M) | ($0.12M) | ($0.01M) |
| Operating Margin %(computed) | — | — | — | -740.70% | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.01M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($0.13M) | ($0.12M) | ($0.99M) | ($0.12M) | ($0.01M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($0.13M) | ($0.12M) | ($0.99M) | ($0.12M) | ($0.01M) |
| Net Margin %(computed) | — | — | — | -732.64% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.00 | $-0.00 | $-0.01 | $-0.00 | $-0.00 |
| Wtd Avg Shares | 99.00M | 96.45M | 96.43M | 91.32M | 96.00M |
| EBITDA | ($0.12M) | $0.00M | $0.00M | $0.00M | $0.00M |
| EBITDA Margin %(computed) | — | 0.00% | 0.00% | 0.00% | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Goldenwell Biotech, Inc. data
About Goldenwell Biotech, Inc. (GWLL) Income Statement
Goldenwell Biotech, Inc. (GWLL) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, GWLL reported revenue of $0.00B, gross profit of $0.00B (gross margin 46.04%), and net income of ($0.00B) — a net profit margin of -94602.88%.
Frequently asked questions
GWLL · 4 questionsGoldenwell Biotech, Inc. (GWLL) reported revenue of $0.00B for 2024, down 94.1% year-over-year.
GWLL revenueGWLL salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09